Cargando…

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy

BACKGROUND: Recent studies have shown that galactose-deficient IgA1 (GdIgA1) has an important role in the pathogenesis of IgA nephropathy (IgAN). Although emerging data suggest that serum GdIgA1 can be a useful non-invasive IgAN biomarker, the localization of nephritogenic GdIgA1-producing B cells r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Junichiro, Suzuki, Yusuke, Suzuki, Hitoshi, Sato, Daisuke, Kano, Tatsuya, Yanagawa, Hiroyuki, Matsuzaki, Keiichi, Horikoshi, Satoshi, Novak, Jan, Tomino, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931817/ https://www.ncbi.nlm.nih.gov/pubmed/24586974 http://dx.doi.org/10.1371/journal.pone.0089707

Ejemplares similares

The Kinetics of Glomerular Deposition of Nephritogenic IgA
por: Yamaji, Kenji, et al.
Publicado: (2014)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
por: Maruyama, Shuntaro, et al.
Publicado: (2016)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Diagnosis and treatment of patients with IgA nephropathy in Japan
por: Tomino, Yasuhiko
Publicado: (2016)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
por: Yanagawa, Hiroyuki, et al.
Publicado: (2014)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020)

Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
por: Reily, Colin, et al.
Publicado: (2018)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series
por: Marumoto, Hirokazu, et al.
Publicado: (2020)

Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy
por: Kajiyama, Tadahiro, et al.
Publicado: (2011)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy
por: Maiguma, Masayuki, et al.
Publicado: (2014)

Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries
por: Makita, Yuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lls3fdmkjt3kupgb24kbr7iu78